A BILL 
To amend the Controlled Substances Act to improve the 
process for conducting scientific research on schedule 
I controlled substances, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Streamlining Research 
4
on Controlled Substances Act of 2021’’. 
5
22:15 May 27, 2021
H2405
2 
•HR 2405 IH
SEC. 2. CLARIFICATION OF CERTAIN REGISTRATION RE-
1
QUIREMENTS RELATED TO RESEARCH. 
2
(a) EXCEPTION FOR AGENTS OR EMPLOYEES OF 
3
REGISTERED RESEARCHERS.—Section 302(c) of the Con-
4
trolled Substances Act (21 U.S.C. 822(c)) is amended in 
5
paragraph (1) by striking ‘‘or dispenser’’ and inserting 
6
‘‘dispenser, or researcher’’. 
7
(b) CONFORMING AMENDMENT.—Section 102(3) of 
8
the Controlled Substances Act (21 U.S.C. 802(3)) is 
9
amended by striking ‘‘or dispenser’’ and inserting ‘‘dis-
10
penser, or researcher’’. 
11
(c) SINGLE REGISTRATION FOR CONTIGUOUS RE-
12
SEARCH SITES.—Section 302(e) of the Controlled Sub-
13
stances Act (21 U.S.C. 822(e)) is amended by adding at 
14
the end the following new paragraph: 
15
‘‘(3) Notwithstanding paragraph (1), a person reg-
16
istered to conduct research with a controlled substance 
17
under section 303(f) may conduct such research under a 
18
single registration if such research occurs exclusively on 
19
a single, contiguous campus and the registrant notifies the 
20
Attorney General in writing of all sites on the campus 
21
where the research will be conducted or where the con-
22
trolled substance will be stored or administered. The reg-
23
istrant must so notify the Attorney General prior to con-
24
ducting research at such additional sites.’’. 
25
22:15 May 27, 2021
H2405
3 
•HR 2405 IH
(d) NEW INSPECTION NOT REQUIRED IN CERTAIN 
1
SITUATIONS.—Section 303(f) of the Controlled Sub-
2
stances Act (21 U.S.C. 823(f)) is amended— 
3
(1) by redesignating paragraphs (1) through 
4
(5) as subparagraphs (A) through (E), respectively, 
5
and by moving the margins of such subparagraphs 
6
two ems to the right; 
7
(2) by striking ‘‘(f) The’’ and inserting ‘‘(f)(1) 
8
The’’; and 
9
(3) by adding at the end, after the matter fol-
10
lowing subparagraph (E), as so redesignated, the 
11
following new paragraph: 
12
‘‘(2)(A) If a person is registered to conduct research 
13
with a controlled substance and applies for a registration, 
14
or a modification of a registration to conduct research 
15
with a second controlled substance that is in the same 
16
schedule or in a schedule with a higher numerical designa-
17
tion, a new inspection by the Attorney General of the reg-
18
istered location is not required. 
19
‘‘(B) Nothing in this paragraph shall prohibit the At-
20
torney General from conducting any inspection if the At-
21
torney General deems it necessary.’’. 
22
(e) CONTINUATION OF RESEARCH ON SUBSTANCES 
23
NEWLY ADDED TO SCHEDULE I; AUTHORITY TO CON-
24
DUCT RESEARCH WITH OTHER SUBSTANCES IN SCHED-
25
22:15 May 27, 2021
H2405
4 
•HR 2405 IH
ULE I.—Section 302 of the Controlled Substances Act (21 
1
U.S.C. 822) is amended by adding at the end the following 
2
new subsection: 
3
‘‘(h) CONTINUATION OF RESEARCH ON SUBSTANCES 
4
NEWLY ADDED TO SCHEDULE I; AUTHORITY TO CON-
5
DUCT RESEARCH WITH OTHER SUBSTANCES IN SCHED-
6
ULE I.— 
7
‘‘(1) If a person is conducting research on a 
8
substance at the time the substance is added to 
9
schedule I, and such person is already registered to 
10
conduct research with a controlled substance in 
11
schedule I or II then— 
12
‘‘(A) the person shall, within 30 days of 
13
the scheduling of the newly scheduled sub-
14
stance, submit a completed application for reg-
15
istration or modification of existing registration, 
16
to conduct research on such substance, in ac-
17
cordance with the regulations issued by the At-
18
torney General; 
19
‘‘(B) the person may, notwithstanding sub-
20
sections (a) and (b), continue to conduct the re-
21
search on such substance until the application 
22
referred to in subparagraph (A) is withdrawn 
23
by the applicant or until the Attorney General 
24
serves on the applicant an order to show cause 
25
22:15 May 27, 2021
H2405
5 
•HR 2405 IH
proposing the denial of the application pursuant 
1
to section 304(c); and 
2
‘‘(C) if the Attorney General serves such 
3
an order to show cause and the applicant re-
4
quests a hearing, such hearing shall be held on 
5
an expedited basis and not later than 45 days 
6
after the request is made, except that the hear-
7
ing may be held at a later time if so requested 
8
by the applicant. 
9
‘‘(2)(A) A person who is registered to conduct 
10
research with a controlled substance in schedule I 
11
may, notwithstanding subsections (a) and (b), con-
12
duct research with another controlled substance in 
13
schedule I, provided the following conditions are 
14
met: 
15
‘‘(i) The person has applied for a modifica-
16
tion of the person’s registration to authorize re-
17
search with such other controlled substance in 
18
accordance with the regulations issued by the 
19
Attorney General. 
20
‘‘(ii) The Attorney General has obtained 
21
verification from the Secretary that the re-
22
search protocol submitted with the application 
23
is meritorious. 
24
22:15 May 27, 2021
H2405
6 
•HR 2405 IH
‘‘(iii) The Attorney General has deter-
1
mined that such activity is consistent with 
2
United States obligations under the Single Con-
3
vention on Narcotic Drugs, 1961. The Attorney 
4
General shall make such determination not 
5
later than 30 days after receiving the applica-
6
tion referred to in clause (i). 
7
‘‘(B) Nothing in this section shall be construed 
8
to alter the authority of the Attorney General to ini-
9
tiate proceedings to deny, suspend, or revoke any 
10
registration in accordance with sections 303 and 
11
304.’’. 
12
(f) TREATMENT OF CERTAIN ACTIVITIES AS COINCI-
13
DENT TO RESEARCH.—Section 302 of the Controlled Sub-
14
stances Act (21 U.S.C. 822), as amended by subsection 
15
(d), is further amended by adding at the end the following 
16
new subsection: 
17
‘‘(i) TREATMENT OF CERTAIN ACTIVITIES AS COIN-
18
CIDENT TO RESEARCH.— 
19
‘‘(1) IN
GENERAL.—Except as specified in 
20
paragraph (2), a person who is registered to perform 
21
research with a controlled substance may perform 
22
the following activities with small quantities of that 
23
substance, as set forth in the relevant statement or 
24
protocol filed with the application for registration 
25
22:15 May 27, 2021
H2405
7 
•HR 2405 IH
approved by the Attorney General without being re-
1
quired to obtain a manufacturing registration: 
2
‘‘(A) Processing the substance to create ex-
3
tracts, tinctures, oils, solutions, derivatives, or 
4
other forms of the substance consistent with the 
5
approved research protocol. 
6
‘‘(B) Dosage form development for the 
7
purpose of satisfying regulatory requirements 
8
implemented by the Food and Drug Adminis-
9
tration for submitting an investigational new 
10
drug application. 
11
‘‘(2) EXCEPTION
REGARDING
MARIHUANA.— 
12
The authority under paragraph (1) does not include 
13
authority to grow marihuana.’’. 
14
SEC. 3. REVIEW OF RESEARCH REGISTRATION PROCESS. 
15
(a) REVIEW.—Not later than one year after the date 
16
of the enactment of this section, the Attorney General and 
17
the Secretary of Health and Human Services shall conduct 
18
a review of the processes used to obtain or modify Federal 
19
authorization to conduct research with controlled sub-
20
stances, including— 
21
(1) an evaluation of the impacts of the amend-
22
ments made by section 2 on the risk of the diversion 
23
of controlled substances used in research and related 
24
public safety considerations; and 
25
22:15 May 27, 2021
H2405
8 
•HR 2405 IH
(2) identification of opportunities to reduce any 
1
unnecessary burden on persons seeking registration, 
2
potential redundancies, and inefficiencies in the 
3
process to obtain or modify Federal authorization to 
4
conduct research with controlled substances, includ-
5
ing the process for obtaining a registration under 
6
section 303 of the Controlled Substances Act (21 
7
U.S.C. 823) and the process by which the Secretary 
8
of Health and Human Services reviews research pro-
9
tocols. 
10
(b) GUIDANCE.—Following the review described in 
11
subsection (a), the Attorney General and the Secretary of 
12
Health and Human Services shall, as appropriate, jointly 
13
issue guidance to registrants and potential registrants 
14
clarifying the process for registration under section 303 
15
of the Controlled Substances Act (21 U.S.C. 823). 
16
Æ 
22:15 May 27, 2021
H2405
